Comparison of choroidal thickness in eyes of diabetic patients with eyes of healthy individuals using optical coherence tomography in a tertiary care hospital

Abstract

Objectives: To compare the choroidal thickness in eyes of diabetic patients with eyes of age matched controls using optical coherence tomography in a tertiary care hospital.
 Methods: This Cross sectional study was conducted at the Department of Ophthalmology, Jinnah Postgraduate Medical Centre Karachi, for six months from13thJanuary 2020 to13thJuly 2020. The study group comprised of 44 patients with 88 eyes. Patients who fulfill the inclusion criteria that is age ranging from 35 to 80years, either gender, known case of diabetes mellitus and having any type of diabetic retinopathy (HbA1c >7), non-diabetic healthy individuals (HbA1c <7) and those giving informed consent were included in the study. However, patients having active ocular infections, history of myocardial infarction, stroke, uveitis, any ocular surgery, lasers, intravitreal injections, poor fundus view and not giving consent were excluded. A pre-designed proforma was filled. A baseline ocular examination was performed and choroidal thickness was assessed from retinal pigment epithelium to choroid sclera junction in diabetic and healthy participants of the study group using high resolution Swept source OCT (DRI-OCT-2 Triton; Topcon).
 Results: The average age of the patients was 39.41±15.95 years. According to our study mean central subfoveal choroidal thickness in diabetic eyes was 268.5 ± 66.22 (95% CI 240 – 297) and in non-diabetic healthy participants it was 339.3 ± 71.49 (95% CI 308 – 369) with a p-value of 0.001. However, average choroidal thickness was 261.8 ± 61.93 (95% CI 235 – 288) and 336.0 ± 74.35 (95% CI 304 – 367) in diabetic and non-diabetic healthy population with a p-value of 0.001. Choroidal thickness comparison between gender in diabetic and non-diabetic population also showed similar trend.
 Conclusion: In this study, mean central choroidal thickness as well as average choroidal thickness was significantly reduced in eyes having diabetic retinopathy as compared to participants with non-diabetic healthy eyes. These findings indicate that changes in choroid may be a probable route in the pathogenesis of diabetic retinopathy.
 doi: https://doi.org/10.12669/pjms.38.1.4443
 How to cite this:Hassan H, Cheema A, Tahir MA, Nawaz HN. Comparison of choroidal thickness in eyes of diabetic patients with eyes of healthy individuals using optical coherence tomography in a tertiary care hospital. Pak J Med Sci. 2022;38(1):---------. doi: https://doi.org/10.12669/pjms.38.1.4443
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The Anatomic and Functional Outcomes of Ozurdex-Aided Vitrectomy in Proliferative Diabetic Retinopathy

“…It has been shown that the normal subfoveal choroidal thickness (SFCT) is 272~448 μm. 25 Compared with normal subjects, the choroid thickness will be reduced by the presence of DME, but at the same time, the choroid can be thickened in the initial stage of DR and become thinner with the progression of DR. 26,27 Studies have shown that the overexpression of some cytokines is associated with the progression of DR, including monocyte chemokine protein-1 (MCP-1), platelet-derived growth factor, VEGF, insulin-like growth factor 1, pigment epithelium-derived factor, and CXC mode-chemokine ligand, can lead to choroid thickening. [28][29][30] As an anti-inflammatory agent, Ozurdex can effectively reduce the inflammatory response and inflammatory factors, 4 while Conbercept can neutralize VEGF to reduce the overexpressed cytokines, 13 they both could restore the thickened choroid to a normal level.…”

Ocular Manifestations of Diabetes: A Cross-Sectional Study

“…Diabetic retinopathy is the most frequently studied ocular finding in diabetic patients. 13 This study was designed to appraise ocular manifestations of diabetes other than diabetic retinopathy in a tertiary care hospital of Pakistan.…”